Serum cytokine concentrations in patients with schizophrenia

Schizophrenia Research

Volumn 20, Issue 1-2, 1996, Pages 199-203

  Baker, Ivory ^a   Masserano, Joseph ^a   Wyatt, Richard Jed ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

cytokines; interleukin 1 ; interleukin 6; schizophrenia; sIL 2r; tumor necrosis factor

Indexed keywords

CYTOKINE; HALOPERIDOL; MOLINDONE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030152374     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(95)00089-5     Document Type: Article

References (24)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd Edition Revised ed.). The Association, Washington, D.C.
2. Bartko, J. and Carpenter, W. (1976) On methods and theory of reliability. J. Nerv. Mental Dis. 163, 307-317.
3. Bigelow, L. and Berthot, B. (1989) The Psychiatric Symptom Assessment Scale (PSAS). Psychopharmcol. Bull. 25, 168-179.
4. Eaton, W.W., Hayard, C. and Ram, R. (1992) Schizophrenia and rheumatoid arthritis: A rev. Schizophr. Res. 6, 181-192.
5. El-Mallakh, R.S., Suddath, R.L. and Wyatt, R.L. (1993) Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Prog. Neuro-Psychopharmacol. and Biol. Psychiatry 17, 383-391.
6. Ganguli, R. and Rabin, B.S. (1993) CD5 positive B lymphocytes in schizophrenia: No alteration in numbers or percentage as compared with control subjects. Psychiatry Res. 48, 69-78.
7. Ganguli, R., McAllister, C.G., Rabin, B.S., Solomon, W., Brar, J.S. and Rehn, T. (1991) Alteration in interleukins and in T lymphocyte subsets in a subgroup of schizophrenics. Biol. Psychiatry 29, 109A.
8. Ganguli, R., Brar, J.S., Chengappa, K.N., Yang, Z.W., Nimgaonkar, V.L. and Rabin, B.S. (1993) Autoimmunity in schizophrenia: A review of recent findings. Ann. Med. 25, 489-496.
9. Ganguli, R., Yang, Z., Shurin, G., Chengappa, K.N., Brar, J.S., Gubbi, A.V. and Rabin, B.S. (1994) Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness. Psychiatry Res. 51, 1-10.
10. Ganguli, R., Brar, J., Chengappa, K., DeLeo, M., Yang, Z., Shurin, G. and Rabin, B. (1995) Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. Arch. Gen. Psychiatry 52, 668-672.
11. Jeste, D.V. and Wyatt, R.J. (Eds.) (1982) Understanding and Treating Tardive Dyskinesia. Guilford Press, New York, pp. 363.
12. Katila, H., Appelberg, B., Hurme, M. and Rimon, R. (1994) Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr. Res. 12, 29-34.
13. Kirch, D.G. (1993) Infection and autoimmunity as etiologic factors in schizophrenia: A review and reappraisal. Schizophr. Bull. 19, 355-370.
14. Levene, H. (1960). Robust tests for the equality of variances. In: I. Olkin (Ed.), Contributions to probability and Statistics. Stanford Univ. Press.
15. Licinio, J., Seibyl, J.P., Altemus, M., Charney, D.S. and Krystal, J.H. (1993) Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am. J. Psychiatry 150, 1408-1410.
16. McAllister, C., van Kammen, D., Rehn, T., Miller, A., Gurklis, J., Kelly, M., Yao, J. and Peters, J. (1995) Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am. J. Psychiatry 152, 9, 1291-1297.
17. Rapaport, M.H., McAllister, C.G., Pickar, D., Nelson, D.L. and Paul, S.M. (1989) Elevated levels of soluble interleukin-2 receptors in schizophrenia. Arch. Gen. Psychiatry 46, 291-292.
18. Rapaport, M.H., McAllister, C.G., Kirch, D.G. and Pickar, D. (1991) The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol. Psychiatry 29, 715-717.
19. Rapaport, M.H., Torrey, E.F., McAllister, C.G., Nelson, D.L., Pickar, D. and Paul, S.M. (1993) Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur. Arch. Psychiatry Clin. Neurosci. 243, 7-10.
20. Shintani, F., Kanba, S., Maruo, N., Nakaki, T., Nibuya, M., Suzuki, E., Kinoshita, N. and Yagi, G. (1991) Serum interleukin-6 in schizophrenic patients. Life Sci. 49, 661-664.
21. Spitzer, R., Williams, J., Gibbon, M. and First, M. (1990) Structured Clinical Interview for DSM-III-R Non-Patient Edition. American Psychiatric Press, Washington, DC.
22. Welch, B.L. (1951) On the comparison of several mean values: An alternative approach. Biometrika 38, 330-336.
23. Wyatt, R., Egan, M. and Kirch, D.G. Schizophrenia: Biochemical, endocrine, and immunological studies. In: H.K.B. Sadock (Ed.), Comprehensive Textbook of Psychiatry. Williams and Wilkens, Baltimore, MD. 1995, pp. 927-942.
24. Xu, H.-M., Wei, J. and Hemmings, G.P. (1994) Changes in plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment of schizophrenia. Br. J. Psychiatry 164, 251-253.